AESGP

AESGP, the Association of the European Self-Care Industry, generally welcomes the European Commissions legislative proposal on simplifying and reducing the burden of the rules on medical devices aiming to improve the functioning of the current regulatory framework, notably regarding the smooth functioning of the single market for medical devices, while ensuring a high level of health protection for patients and…

AESGP Feedback to the European Commissions Call for Evidence on Targeted revision of the EU rules for medical devices and in vitro diagnostics. AESGP, the Association of the European Self-Care Industry, represents the manufacturers of non-prescription medicines, food supplements, and self-care medical devices in Europe, an area also referred to as self-care or consumer healthcare products.

AESGP, the Association of the European Self-Care Industry, represents the manufacturers of non-prescription medicines, food supplements, and self-care medical devices in Europe, an area also referred to as self-care or consumer healthcare products. Please find AESGPs detailed comments in the attached file.

AESGP expresses support for the Commission Proposal to revise the EU general pharmaceutical legislation. We believe this long-awaited revision will consolidate and streamline legislation which underwent multiple updates over the past 20 years. While AESGP members acknowledge the legislation's goals, we raise concerns on unintended consequences for non-prescription medicines (NPMs).

A FIT PHARMACEUTICAL LEGISLATION TO BENEFIT E.U. CITIZENS AND HEALTH SYSTEMS AESGP supports a pragmatic and risk-based regulatory framework that fosters a stronger role for self-care and prevention. The current structure is overall fit for purpose although some issues may arise from divergent interpretation, disharmonised application and addition of gold plating or administrative elements.

AESGP welcomes the European Commission’s effort to develop a European approach for artificial intelligence (AI) that promotes Europe’s innovation capacity while ensuring the creation of an ethical and trustworthy AI. If properly addressed, AI could bring tremendous benefits to the healthcare sector as a whole and some of its potential applications are already described in numerous publications.

AESGP feedback European Commission’s proposal for a Directive on substantiation and communication of explicit environmental claims (Green Claims Directive) July 2023 AESGP, the Association of the European Self-Care Industry, is interested to provide input on the public consultation concerning the published legislative proposal for a Directive on the Substantiation and Communication of Explicit Environmental Claims…

Opening of the attached position paper · the full paper is on the Commission’s record (source link above)

The European Association of the Self-Care Industry (AESGP) expresses its full support for the overarching objectives of the Chemical Strategy for Sustainability (CSS). Furthermore, the AESGP welcomes the chance to offer feedback on the open public consultation regarding the Revision of the Regulation on Classification, Labelling, and Packaging of Substances and Mixtures (CLP).

Accompany enhanced data sharing with necessary (digital) literacy programs AESGP welcomes the European Commission’s proposal for a regulation on the European Health Data Space and its ambition to support innovation, take advantage of digital technology developments and deliver concrete results to improve healthcare in Europe.

LET THE KNOWLEDGE CONTAINED IN DATA OPEN DOORS TO THE FUTURE OF HEALTHCARE AESGP welcomes the European Commission’s Combined Evaluation Roadmap and Inception Impact Assessment on A European Health Data Space and its ambition to introduce innovation, to take advantage of digital technology developments and to deliver concrete results to improve healthcare in Europe.

As the European association representing manufacturers of self-care products, including non-prescription medicines, medical devices, and food supplements, AESGP supports the main objectives of the Packaging and Packaging Waste Regulation (PPWR) to promote circularity and contribute to a more resource-efficient packaging system across the European Union.

As the European association representing manufacturers of self-care products, including non-prescription medicines, medical devices, and food supplements, AESGP supports the main objectives of the Packaging and Packaging Waste Regulation (PPWR) to promote circularity and contribute to a more resource-efficient packaging system across the European Union.

AESGP welcomes the opportunity to submit feedback to the UWWTD proposal, due to direct impact on pharmaceutical industry, by including an Extended Producer Responsibility (EPR) scheme to finance the establishment of quaternary treatment in UWWTPs to deal with contaminants of emergent concern (CEC).

As the European association representing manufacturers of self-care products, including non-prescription medicines, medical devices, and food supplements, AESGP supports the main objectives of the Packaging and Packaging Waste Regulation (PPWR) to promote circularity and contribute to a more resource-efficient packaging system across the European Union.

AESGP, the Association of the European Self-Care Industry, is a non-profit organisation that represents the manufacturers of non-prescription medicines, food supplements, and self-care medical devices in Europe, an area also referred to as self-care or consumer healthcare products, takes the opportunity to share its views on the One Substance, One Assessment (OSOA) package of legislative proposals published on 7…

AESGP, the Association of the European Self-Care Industry, represents the manufacturers of non-prescription medicines, food supplements, and self-care medical devices in Europe, an area also referred to as “self-care” or “consumer healthcare” products.

AESGP, the Association of the European Self-Care Industry, is a non-profit organisation that represents the manufacturers of non-prescription medicines, food supplements, and self-care medical devices in Europe, an area also referred to as self-care or consumer healthcare products, takes the opportunity to share its views on the One Substance, One Assessment (OSOA) package of legislative proposals published on 7…

AESGP, the Association of the European Self-Care Industry, is a non-profit organisation that represents the manufacturers of non-prescription medicines, food supplements, and self-care medical devices in Europe, an area also referred to as self-care or consumer healthcare products, takes the opportunity to share its views on the One Substance, One Assessment (OSOA) package of legislative proposals published on 7…

AESGP welcomes the consultation initiative and the stakeholder engagement on the principle of ‘One Substance – One Assessment’ as part of the commitment in the ‘European Green Deal’. It is essential for AESGP that the implementation of the ‘One Substance - One Assessment’ (OSOA) concept which aims to reduce the administrative burden, duplication of efforts and to optimize resources does not have a negative impact on…

AESGP, the Association of the European Self-Care Industry, represents the manufacturers of non-prescription medicines, food supplements, and self-care medical devices in Europe, an area also referred to as “self-care” or “consumer healthcare” products. AESGP welcome the opportunity to provide our feedback on the foreseen proposal for a founding regulation of the European Chemicals Agency (ECHA).

AESGP, the Association of the European Self-Care Industry, represents the manufacturers of self-care medical devices, non-prescription medicines, and food supplements in Europe, an area also referred to as self-care or consumer healthcare products.

The Association of the European Self-Care Industry (AESGP) along with the European Federation of Pharmaceutical Industries and Associations (EFPIA) and Medicines for Europe (MfE) note positive aspects in the revision of the Directive 2000/60/EC establishing a framework for Community action in the field of water policy, Directive 2006/118/EC on the protection of groundwater against pollution and deterioration and the…

AESGP welcomes the proposed technical framework for HealthData@EU and would like to highlight three aspects that are critical for the long-term value, interoperability and scientific utility of the European Health Data Space. 1. Future-proof metadata standards and capture of OTC medicines Metadata requirements should be designed to support future use cases and evolving research needs.

The Association of the European Self-Care Industry (AESGP) appreciates the opportunity provided by the Commission to comment on the draft Commission Regulation amending Annex III to Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards botanical species containing hydroxyanthracene derivatives (HAD).

AESGP welcomes the opportunity to comment on the draft Commission Implementing Act laying down the measures for the establishment and operation of the European Health Data Space (EHDS) Board. AESGP expresses its support for the establishment of the EHDS Board, recognizing it as a fundamental component for achieving a successful and harmonised implementation of the EHDS.

AESGP, the Association of the European Self-Care Industry, welcomes the opportunity to provide feedback on the performance of the European Food Safety Authority (EFSA) as part of its evaluation for the period 2017-2024. You will find our feedback attached. We thank you in advance for your consideration.

The Association of the European Self-Care Industry (AESGP), representing the European manufactures of consumer healthcare products (including non-prescription medicines and selfcare medical devices), would like to use the opportunity provided by the Commission to comment on the draft Regulation on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and…

Please see below the AESGP comments on the European Commission proposal on updating the rules on fees payable to the European Medicines Agency. The detailed comments are provided in the attached document. The EMA is currently funded at 86% by fees, 13% by EU contribution and 1% by other sources.